Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rink

Showing results (271-280 of 292) with videos related to

Pageof 30
Sort By:
Journal of Clinical Medicine|August 10, 2019
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival OutcomesMarco Moschini, Stefania Zamboni, Francesco Soria, et al.
BJUI Compass|June 14, 2024
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease courseHenning Plage, Kira Furlano, Jörg Neymeyer, et al.
BJU International|March 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancerMarkus von Deimling, Laura S Mertens, Marc Furrer, et al.
European Urology Oncology|January 23, 2024
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant ChemotherapySean A Fletcher, Maximilian Pallauf, Emelia K Watts, et al.
Pathologica|July 8, 2025
KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladderFlorian Viehweger, Natalia Gorbokon, Seyma Büyücek, et al.
Frontiers in Oncology|January 29, 2024
Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomasJan H Müller, Henning Plage, Sefer Elezkurtaj, et al.
European Urology|February 21, 2024
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial CancerNicolaus F Debatin, Elena Bady, Tim Mandelkow, et al.
BJU International|July 4, 2024
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleedingLuca Antonelli, Pedro David Wendel-Garcia, Manja Deforth, et al.
Cancers|March 11, 2023
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched AnalysisNico C Grossmann, Francesco Soria, Tristan Juvet, et al.
European Urology Focus|July 21, 2017
Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical CystectomyLuis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Pageof 30

Showing results (271-280 of 292) with videos related to

Sort By:
Pageof 30
Journal of Clinical Medicine|August 10, 2019
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival OutcomesMarco Moschini, Stefania Zamboni, Francesco Soria, et al.
BJUI Compass|June 14, 2024
CEA (CEACAM5) expression is common in muscle-invasive urothelial carcinoma of the bladder but unrelated to the disease courseHenning Plage, Kira Furlano, Jörg Neymeyer, et al.
BJU International|March 12, 2024
The optimal number of induction chemotherapy cycles in clinically lymph node-positive bladder cancerMarkus von Deimling, Laura S Mertens, Marc Furrer, et al.
European Urology Oncology|January 23, 2024
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant ChemotherapySean A Fletcher, Maximilian Pallauf, Emelia K Watts, et al.
Pathologica|July 8, 2025
KDM6A expression loss is frequent in low grade non-invasive urothelial carcinomas of the urinary bladderFlorian Viehweger, Natalia Gorbokon, Seyma Büyücek, et al.
Frontiers in Oncology|January 29, 2024
Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomasJan H Müller, Henning Plage, Sefer Elezkurtaj, et al.
European Urology|February 21, 2024
Prognostic Impact and Spatial Interplay of Immune Cells in Urothelial CancerNicolaus F Debatin, Elena Bady, Tim Mandelkow, et al.
BJU International|July 4, 2024
Thromboprophylaxis during neoadjuvant chemotherapy for bladder cancer reduces thromboembolism and bleedingLuca Antonelli, Pedro David Wendel-Garcia, Manja Deforth, et al.
Cancers|March 11, 2023
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched AnalysisNico C Grossmann, Francesco Soria, Tristan Juvet, et al.
European Urology Focus|July 21, 2017
Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical CystectomyLuis A Kluth, Evanguelos Xylinas, Malte Rieken, et al.
Pageof 30